Integration of azithromycin mass administration to 1–11-month-old children into an existing health platform to reduce child mortality: a cluster-randomised trial in Burkina Faso

Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more evidence is needed to support targeting a narrower age range of 1–11 months. This trial assesses the efficacy of azithromycin MDA to 1–11-month-old children in reducing mortality...

全面介紹

書目詳細資料

Principais autores:	Thomas M Lietman, Ali Sie, Elodie Lebas, Mamadou Bountogo, Mamadou Ouattara, Boubacar Coulibaly, Kieran S O’Brien, Fanny Yago-Wienne, Issouf Bamba, Benjamin Arnold, Brittany Peterson, Valérie Zombré, Djeinam Toure, Georges Dimithé, Regina Khassanova, Souleymane Sidibé, Pouorinibé Noel Some
格式:	Artigo
語言:	Inglês
出版:	BMJ Publishing Group 2026-01-01
叢編:	BMJ Global Health
在線閱讀:	https://gh.bmj.com/content/11/1/e021336.full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!